95965 ā
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more PāC bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups Arylalkanephosphonic acids
COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#2SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES
#3COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#4LIGHT ABSORBING AGENT, COMPOSITION, OPTICAL MEMBER, AND METHOD OF MANUFACTURING LIGHT ABSORBING AGENT
#5SMALL MOLECULE DEGRADERS OF STAT3
#6Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#7LIGANDS FOR NANO-SIZED MATERIALS
#8Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#9STAT3 dimerization inhibitors
#10SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF
#11STAT3 dimerization inhibitors
#12Bisphosphonates vinylic monomers and polymers and uses thereof
#13Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#14Electrochromic element and electrochromic dimming element
#15CYP-eicosanoid derivatives
#16Therapeutic bisphosphonates
#17STAT3 dimerization inhibitors
#18Inhibitors of protein tyrosine phosphatases
#19Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
#20Bisphosphonates vinylic monomers and polymers and uses thereof
#21Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#22Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#23Surface-modified pigment preparations
#24AROMATIC COMPOUNDS BEARING AT LEAST ONE PHOSPHONATE OR PHOSPHINATE GROUP, PREPARATION METHOD AND USES THEREOF
#25Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#26Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases
#27NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY
#28Phosphonic acid compounds as inhibitors of serine proteases
#29Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#30Fluorinated arylene-containing compounds, methods, and polymers prepared therefrom
#31Phosphonic acid compounds as inhibitors of serine proteases
#32Inhibitors of autotaxin
#33Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same
#34ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS
#35Plasma Carboxypeptidase B Inhibitors
#36Phosphonic acid compounds as inhibitors of serine proteases
#37Cycloalkane-containing sphingosine 1-phosphate agonists
#38Phosphonic acid compounds as inhibitors of serine proteases
#39Phosphonic acid compounds as inhibitors of serine proteases
#40Phosphonic acid compounds as inhibitors of serine proteases
#41Novel Phosphorus-Containing Thyromimetics
#42Carbene precursor compound for producing an adhesive surface on a substrate
#43aSMase inhibitors
#44Phosphonate derivatives as autotaxin inhibitors
#45Thioaryl substituted inhibitors of zinc proteases and their use
#46METHOD OF SEPARATING METALLIC AND SEMICONDUCTING CARBON NANOTUBES FROM A MIXTURE OF SAME
#47Phosphonic acid compounds as inhibitors of serine proteases
#48Novel phosphonic acid compounds as inhibitors of serine proteases
#49Novel phosphonic acid compounds as inhibitors of serine proteases
#50Phosphonic acid compounds as inhibitors of serine proteases
#51Novel phosphonic acid compounds as inhibitors of serine proteases
#52Phosphonic acid compounds as inhibitors of serine proteases
#53Novel phosphonic acid compounds as inhibitors of serine proteases
#54Phosphorus-containing thyromimetics
#55Phosphonic acid compounds as inhibitors of serine proteases
#56Novel phosphonic acid compounds as inhibitors of serine proteases
#57Plasma carboxypeptidase B inhibitors
#58Organophosphoric derivatives useful as anti-parasitic agents
#59Aminophosphonic acid derivative, salt thereof, and modulator of S1P receptor
#60Cycloalkane-containing sphingosine 1-phosphate agonists
#61Therapeutic amides
#62Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
#63Invertible amphiphilic polymers
#64Therapeutic cyclopentane derivatives
#65Flame Retardants
#66Aminoalkylphosphonates and related compounds as Edg receptor agonists
#67Ptb1b photoprobes
#68Production method for aminophosphonic acid derivatives
#69Substituted phosphonate fluorescent sensors and use thereof
#70METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES
#71Diarylsulfone sulfonamides and use thereof
#72Plasma carboxypeptidase B inhibitors
#73Diarylurea derivatives and their use as chloride channel blockers
#74Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
#75Trisubstituted nitrogen modulators of tyrosine phosphatases
#76Aminoalkylphosphonates and related compounds as Edg receptor agonists
#77Phosphorus-containing thyromimetics
#78Protein kinase inhibitors
#79Metal phosphonates and related nanocomposites
#80Benzenedicarboxylic acid derivatives
#81Il-6 production inhibitors
#82Novel lysophosphatidic acid receptor agonists and antagonists
#83Aminoalkylphosphonates and related compounds as edg receptor agonists
#84Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
#85Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases
#86Perfluoropolyether amide-linked phosphonates, phosphates, and derivatives thereof
#87Self-assembly of nanostructures